Improved outcomes with “7+3” induction chemotherapy for acute myeloid leukemia over the past four decades: analysis of SWOG trial data

We have previously shown that complete response (CR) rates and overall survival of patients with acute myeloid leukemia have improved since the 1980s. However, we have not previously evaluated how the length of first CR (CR1) has changed over this time period. To address this, we analyzed 1,247 pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Othus, Megan, Garcia-Manero, Guillermo, Godwin, John E., Weick, James K., Appelbaum, Frederick R., Erba, Harry P., Estey, Elihu H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2022
Materias:
Article - Acute Myeloid Leukemia
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827148/
https://www.ncbi.nlm.nih.gov/pubmed/35833298
http://dx.doi.org/10.3324/haematol.2022.280765

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827148/
https://www.ncbi.nlm.nih.gov/pubmed/35833298
http://dx.doi.org/10.3324/haematol.2022.280765

Ejemplares similares